# CHOLESTYRAMINE
> **ANDA214877** · Abbreviated New Drug Application (Generic) · Sponsor: AIPING PHARM INC · Approved 2022-01-21
## Drug
- **FDA Application Number:** ANDA214877
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CHOLESTYRAMINE
- **Generic name:** Cholestyramine
- **Active ingredients:** CHOLESTYRAMINE
- **Dosage form:** POWDER
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** AIPING PHARM INC
- **First approval:** 2022-01-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214877)
---
*AI Analytics · CC0 1.0*